Cargando…
Biosimilarity and Interchangeability: Principles and Evidence: A Systematic Review
BACKGROUND: The efficacy, safety and immunogenicity risk of switching between an originator biologic and a biosimilar or from one biosimilar to another are of potential concern. OBJECTIVES: The aim was to conduct a systematic literature review of the outcomes of switching between biologics and their...
Autores principales: | McKinnon, Ross A., Cook, Matthew, Liauw, Winston, Marabani, Mona, Marschner, Ian C., Packer, Nicolle H., Prins, Johannes B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814534/ https://www.ncbi.nlm.nih.gov/pubmed/29344876 http://dx.doi.org/10.1007/s40259-017-0256-z |
Ejemplares similares
-
The Automatic Substitution of Biosimilars: Definitions of Interchangeability are not Interchangeable
por: Afzali, Anita, et al.
Publicado: (2021) -
Interchangeability of Biosimilars: What Level of Clinical Evidence is Needed to Support the Interchangeability Designation in the United States?
por: Alvarez, Daniel F., et al.
Publicado: (2020) -
Focus on biosimilar etanercept – bioequivalence and interchangeability
por: Cantini, Fabrizio, et al.
Publicado: (2018) -
Biosimilar and interchangeable: Inseparable scientific concepts?
por: de Mora, Fernando, et al.
Publicado: (2019) -
Interchangeability of Biosimilars: Overcoming the Final Hurdles
por: Barbier, Liese, et al.
Publicado: (2021)